<DOC>
	<DOC>NCT02164435</DOC>
	<brief_summary>This is a prospective, single centre clinical investigation looking at short (6 months) and long term (24 months) changes in cardiac function and renal function in patients with drug-resistant hypertension post renal sympathetic denervation.</brief_summary>
	<brief_title>Effects of Renal Sympathetic Denervation on the Cardiac and Renal Functions in Patients With Drug-resistant Hypertension Through MRI Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Subject must be able and willing to comply with the required followup schedule Therapeutic Goods Association approved indications for EnligHTN™ Renal Denervation System Subject is ≥ 18 years of age at time of consent Subject has office SBP ≥ 160 mmHg (except for subjects with Diabetes Mellitus who must demonstrate an office SBP of ≥ 150 mm Hg) within 14 days of the procedure ◦Subject is taking ≥ 3 antihypertensive medications concurrently at maximum tolerated dose (this must include one diuretic) or subject has a documented intolerance to at least 2 out of the 4 major classes of antihypertensives (ACE/ARB, CCB, Diuretics, Beta Blockers and is unable to take 3 antihypertensive drugs. Standard CMR exclusions; implanted cardiac device intracranial metallic implants claustrophobia Gadoliniumspecific: estimated GFR &lt;60 mls/min (usual clinical cutoff is &lt;30 mls/min). Adenosinespecific: asthma / reactive airways disease &gt;first degree atrioventricular block concomitant use of dipyridamole or theophylline consumption of caffeine within 48 hours of proposed investigation EnligHTN™ Renal Denervation System exclusion criteria: Subject has an identified cause of secondary hypertension Subject has an estimated GFR &lt;45 mL/min per 1.73 m2 using the MDRD formula Subject has undergone prior renal angioplasty, indwelling renal stents, and/or aortic stent grafts Subject has haemodynamically significant valvular heart disease Subject has a life expectancy less than 12 months, as determined by the PI Subject is participating in another clinical study Subject is pregnant, nursing, or of childbearing potential and is not using adequate contraceptive methods Subject has renal arteries with diameter(s) &lt; 4 mm in diameter</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Uncontrolled hypertension</keyword>
	<keyword>Renal denervation</keyword>
	<keyword>Renal artery</keyword>
</DOC>